| pubmed-article:19757839 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C1709915 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C0559956 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C0243071 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C1999230 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C1707494 | lld:lifeskim |
| pubmed-article:19757839 | lifeskim:mentions | umls-concept:C0051874 | lld:lifeskim |
| pubmed-article:19757839 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:19757839 | pubmed:dateCreated | 2009-9-17 | lld:pubmed |
| pubmed-article:19757839 | pubmed:abstractText | The histidine residue in angiotensin IV was replaced by various conformationally constrained amino acids. The substitution of the His(4)-Pro(5) dipeptide sequence by the constrained Trp analogue Aia-Gly, in combination with beta(2)hVal substitution at the N-terminus, provided a new stable analogue H-(R)-beta(2)hVal-Tyr-Ile-Aia-Gly-Phe-OH (AL-40) that is a potent ligand for the Ang IV receptor IRAP and selective versus AP-N and the AT1 receptor. | lld:pubmed |
| pubmed-article:19757839 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19757839 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19757839 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19757839 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:19757839 | pubmed:issn | 1520-4804 | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:TourwéDirkD | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:VauquelinGeor... | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:VanderheydenP... | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:DemaegdtHeidi... | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:LukaszukAneta... | lld:pubmed |
| pubmed-article:19757839 | pubmed:author | pubmed-author:FeytensDebbyD | lld:pubmed |
| pubmed-article:19757839 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19757839 | pubmed:day | 24 | lld:pubmed |
| pubmed-article:19757839 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:19757839 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19757839 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19757839 | pubmed:pagination | 5612-8 | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:meshHeading | pubmed-meshheading:19757839... | lld:pubmed |
| pubmed-article:19757839 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19757839 | pubmed:articleTitle | The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues. | lld:pubmed |
| pubmed-article:19757839 | pubmed:affiliation | Department of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium. | lld:pubmed |
| pubmed-article:19757839 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19757839 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:19757839 | lld:chembl |
